Application of Magnetic Resonance Spectroscopy in Patients with Alternating Hemiplegia of Childhood: Findings on Metabolic Dysfunctions

Abstract

Objective Alternating hemiplegia of childhood (AHC) is a rare neurodevelopmental syndrome of uncertain etiology. Although the use of magnetic resonance spectroscopy (MRS) for the study of neurologic diseases has grown rapidly over the past decade, its use for AHC patients is quite new. This study was aimed at investigating changes of brain metabolites in patients with alternating hemiplegia of childhood (AHC) during the hemiplegic ictal phases and interictal phases by proton magnetic resonance spectroscopy (¹H-MRS).

Methods ¹H-MRS was used in AHC patients during the hemiplegic ictal phases and interictal phases to evaluate functional activity in certain brain regions. A total of 10 unmedicated, healthy volunteers served as controls.

Results N-acetylaspartate (NAA)/Creatine(Cr) ratio of the frontal lobes, basal ganglia, and temporal lobes in contralateral hemiplegic hemisphere of AHC patients during the ictal phases was significantly lower than that in AHC patients during interictal phases and control subjects. Significantly increased choline-containing compounds (Cho)/Cr were obtained in corresponding regions.

Conclusions These findings suggest neuronal metabolic dysfunctions in frontal lobes, temporal lobes and basal ganglia in AHC patients during ictal phases that perhaps are involved in the pathogenesis of AHC.

Keywords

alternating hemiplegia - childhood - magnetic resonance spectroscopy

• References

• 1 Sweney MT, Silver K, Gerard-Blanluet M , et al. Alternating hemiplegia of childhood: early characteristics and evolution of a neurodevelopmental syndrome. Pediatrics 2009; 123 (3) e534-e541
• 2 Aicardi J. Alternating hemiplegia of childhood. Int Pediatr 1987; 2: 115-119
• 3 Mulas F, Smeyers P, Barbero P, Pitarch I, Velasco RP. [Alternating hemiplegia in young babies]. Rev Neurol 2002; 34 (2) 157-162
• 4 Sasaki M, Sakuma H, Fukushima A, Yamada K, Ohnishi T, Matsuda H. Abnormal cerebral glucose metabolism in alternating hemiplegia of childhood. Brain Dev 2009; 31 (1) 20-26
• 5 Silver K, Andermann F. Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology 1993; 43 (1) 36-41
• 6 Pfund Z, Chugani DC, Muzik O , et al. Alpha[11C] methyl-L-tryptophan positron emission tomography in patients with alternating hemiplegia of childhood. J Child Neurol 2002; 17 (4) 253-260
• 7 Swoboda KJ, Kanavakis E, Xaidara A , et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann Neurol 2004; 55 (6) 884-887
• 8 de Vries B, Stam AH, Beker F , et al. CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhood. Cephalalgia 2008; 28 (8) 887-891
• 9 Inui T, Saito Y, Sakuma H , et al. Profiles of blood biomarkers in alternating hemiplegia of childhood—increased MMP-9 and decreased substance P indicates its pathophysiology. Brain Dev 2012; 34 (3) 196-200
• 10 Auvin S, Joriot-Chekaf S, Cuvellier JC , et al. Small vessel abnormalities in alternating hemiplegia of childhood: pathophysiologic implications. Neurology 2006; 66 (4) 499-504
• 11 Sasaki M, Matsufuji H, Inui T, Arima K. Absence of small-vessel abnormalities in alternating hemiplegia of childhood. Brain Dev 2011; 33 (5) 390-393
• 12 Rosewich H, Thiele H, Ohlenbusch A , et al. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol 2012; 11 (9) 764-773
• 13 Hsu YY, Du AT, Schuff N, Weiner MW. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol 2001; 14 (3) 145-166
• 14 Demougeot C, Marie C, Giroud M, Beley A. N-acetylaspartate: a literature review of animal research on brain ischaemia. J Neurochem 2004; 90 (4) 776-783
• 15 Gupta RK, Cloughesy TF, Sinha U , et al. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000; 50 (3) 215-226
• 16 Speck O, Thiel T, Hennig J. Grading and therapy monitoring of astrocytomas with 1H-spectroscopy: preliminary study. Anticancer Res 1996; 16 (3B): 1581-1585
• 17 Tedeschi G, Bertolino A, Righini A , et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 1995; 45 (7) 1384-1391
• 18 Danysz W, Zajaczkowski W, Parsons CG. Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol 1995; 6 (5 And 6): 455-474
• 19 Modrego PJ, Fayed N. Longitudinal magnetic resonance spectroscopy as marker of cognitive deterioration in mild cognitive impairment. Am J Alzheimers Dis Other Demen 2011; 26 (8) 631-636
• 20 Kantarci K. ¹H magnetic resonance spectroscopy in dementia. Br J Radiol 2007; 80 (Spec No 2): S146-S152
• 21 Kantarci K, Petersen RC, Boeve BF , et al. 1H MR spectroscopy in common dementias. Neurology 2004; 63 (8) 1393-1398
• 22 Kantarci K, Smith GE, Ivnik RJ , et al. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J Int Neuropsychol Soc 2002; 8 (7) 934-942
• 23 Fons C, Campistol J, Panagiotakaki E , et al; ENRAH Consortium. Alternating hemiplegia of childhood: metabolic studies in the largest European series of patients. Eur J Paediatr Neurol 2012; 16 (1) 10-14
• 24 Hammen T, Kuzniecky R. Magnetic resonance spectroscopy in epilepsy. Handb Clin Neurol 2012; 107: 399-408
• 25 Trabka-Janik E, Kułaga A, Urbanik A, Szczudlik A, Grzybek M. [Magnetic resonance spectroscopy (HMRS) in migraine]. Przegl Lek 2010; 67 (4) 251-255